Au­to­lus claims a CAR-T win at EHA; Ima­go touts two PhII tri­al wins for rare dis­ease drug

Pre­sen­ta­tions at the Eu­ro­pean Hema­tol­ogy As­so­ci­a­tion be­gan Fri­day, with Au­to­lus Ther­a­peu­tics re­veal­ing da­ta they say con­tin­ue to show the ben­e­fit of their CAR-T pro­gram. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER